United Kingdom

People: Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

26 Jun 2019
Change (% chg)

$-0.39 (-0.97%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Colpan, Metin 

Dr. Metin Colpan has served as Independent Member of the Supervisory Board of Qiagen N.V. since January 1, 2004. He is a co-founder of QIAGEN and was the Company's Chief Executive Officer and a Managing Director from 1985 through 2003. Dr. Colpan has been a member of the Supervisory Board since 2004 and has served as Chairman of the Science and Technology Committee since 2014. He has been Member of the Selection and Appointment Committee of the Company since 2015. Dr. Colpan obtained his Ph.D. and M.S. in Organic Chemistry and Chemical Engineering from the Darmstadt Institute of Technology in 1983. Prior to founding QIAGEN, Dr. Colpan was an Assistant Investigator at the Institute for Biophysics at the University of Düsseldorf. Dr. Colpan has had wide experience in separation techniques and in the separation and purification of nucleic acids in particular, and has filed many patents in the field. Dr. Colpan also serves as a Supervisory Board member of Qalovis Farmer Automatic Energy GmbH, Laer, Germany. Dr. Colpan previously served as a Supervisory Board member of Ingenium Pharmaceuticals AG, GenPat77 Pharmacogenetics AG, GPC Biotech AG and Morphosys AG, each in Munich, Germany. He received a Master of Science in Chemical Engineering from Technische Universitaet Darmstadt in 1983, and a Doctorate in Philosophy degree in Organic Chemistry from Technische Universitaet Darmstadt in 1983.

Basic Compensation

Total Annual Compensation, USD 75,500
Restricted Stock Award, USD 9,866
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 85,366

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --